Yüklüyor......
Assessment of the Chemosensitizing Activity of TAT-RasGAP(317-326) in Childhood Cancers
Although current anti-cancer protocols are reasonably effective, treatment-associated long-term side effects, induced by lack of specificity of the anti-cancer procedures, remain a challenging problem in pediatric oncology. TAT-RasGAP(317-326) is a RasGAP-derived cell-permeable peptide that acts as...
Kaydedildi:
| Yayımlandı: | PLoS One |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4380404/ https://ncbi.nlm.nih.gov/pubmed/25826368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120487 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|